InMed Pharmaceuticals publicizes new peer-reviewed study

Mugglehead
By Rowan DunneJun 20, 2022, 4:32 pm248 ptsTrending
Less popular cannabinoids such as tetrahydrocannabivarin (THCV) and cannabichromene (CBC) may be used to treat skin conditions, according to a new study promoted by InMed Pharmaceuticals Inc. (Nasdaq: INM). On Tuesday, the company announced the release of a study published in the International Journal of…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Jungle Boys Opening 1st Arizona Dispensary in Phoenix 46

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.